CEPHEID Uncategorized Contracts & Agreements
25 Contracts & Agreements
- CEPHEID 2015 EQUITYINCENTIVE PLAN (adopted February 10, 2015) (Filed With SEC on August 7, 2015)
- CEPHEID 2015 EQUITYINCENTIVE PLAN (adopted February 10, 2015) (Filed With SEC on May 4, 2015)
- [The rest of this page is intentionally left blank.] (Filed With SEC on February 28, 2013)
- Execution Version (Filed With SEC on June 9, 2010)
- Current assets (Filed With SEC on May 7, 2008)
- Exhibit No (Filed With SEC on February 11, 2008)
- Exhibit No (Filed With SEC on February 11, 2008)
- Current assets (Filed With SEC on November 5, 2007)
- Current assets (Filed With SEC on May 10, 2007)
- Current assets (Filed With SEC on May 10, 2007)
- Exhibit No (Filed With SEC on February 20, 2007)
- Exhibit No (Filed With SEC on January 29, 2007)
- Exhibit No (Filed With SEC on November 6, 2006)
- Current assets (Filed With SEC on August 8, 2006)
- Description of Exhibit (Filed With SEC on March 8, 2006)
- Sample preparation procedures that must be performed to isolate the target cells and to separate and purify their nucleic acids, such as DNA and RNA (Filed With SEC on February 22, 2006)
- Current assets (Filed With SEC on November 4, 2005)
- Current assets (Filed With SEC on November 4, 2005)
- Current assets (Filed With SEC on November 4, 2005)
- Current assets (Filed With SEC on August 4, 2005)
- Current assets (Filed With SEC on August 4, 2005)
- Exhibit No (Filed With SEC on May 16, 2005)
- Exhibit No (Filed With SEC on April 6, 2005)
- EXHIBITA (Filed With SEC on March 12, 2004)
- Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Filed With SEC on August 14, 2003)